Human Microbiome in Health and Disease - Part B

1st Edition, Volume 192 - October 22, 2022
Imprint: Academic Press
Editors: Bhabatosh Das, Vijai Singh
Language: English
Hardback ISBN:
9 7 8 - 0 - 3 2 3 - 9 1 2 1 0 - 5
eBook ISBN:
9 7 8 - 0 - 3 2 3 - 9 1 3 2 1 - 8

Human Microbiome in Health and Disease, Volume 192, Part B includes chapters surrounding the role of human microbiome in different diseases. Chapters in this comprehensive new vo… Read more

Human Microbiome in Health and Disease - Part B

Purchase options

BLOOM INTO SPRING SAVINGS

Save up to 25% on books and eBooks!

Shop now

Institutional subscription on ScienceDirect

Request a sales quote

Human Microbiome in Health and Disease, Volume 192, Part B includes chapters surrounding the role of human microbiome in different diseases. Chapters in this comprehensive new volume include The microbiome and communicable diseases, Gut Microbiome and Antimicrobial Resistance in bacterial pathogens, Dysbiosis of human microbiome and infectious disease, Gastrointestinal microbiome in the context of infection in stomach and gastroduodenal diseases, Respiratory tract microbiome and pneumonia, Gut microbiome and neonatal sepsis, Diarrheal disease and gut microbiome, The microbiome and non-communicable diseases, Gut microbiome and inflammatory bowel disease, Gut microbiome and undernutrition, Human microbiome and cardiovascular disease, and much more.

Cover image
Title page
Table of Contents
Copyright
Contributors
Preface
Chapter One: Gut microbiome in the emergence of antibiotic-resistant bacterial pathogens
Abstract
1: Introduction
2: Community structure of gut-microbiota
3: Gut microbiome is a potential reservoir of antibiotic-resistant genes
4: Microbiome: Accumulated effects of antibiotic exposure
5: Factors affecting gut resistome and spread of ARGs
6: Gut microbiome: A well-known transporter of antibiotic resistance gene
7: Different approaches to study and understand human gut-resistome
8: Conclusion and future perspective
References
Further reading
Chapter Two: Dysbiosis of human microbiome and infectious diseases
Abstract
1: Introduction
2: Diseases associated with dysbiosis
3: Protective role of the host microbiota during diseases
4: Targeting the gut microbiota during digestive diseases
5: Conclusion and future perspectives
References
Chapter Three: Gastrointestinal microbiome in the context of Helicobacter pylori infection in stomach and gastroduodenal diseases
Abstract
1: Introduction
2: Gastric diseases
3: H. pylori and gastroduodenal diseases
4: Human gastrointestinal microbiome and gastroduodenal diseases
5: The “other” gastrointestinal microbiomes and their relationships with H. pylori infection and gastroduodenal diseases
6: Factors affecting the gastrointestinal microbiome
7: Conclusion and future perspectives
Acknowledgments
References
Chapter Four: Respiratory tract microbiome and pneumonia
Abstract
1: Introduction
2: Respiratory system and respiratory tract microbiome
3: Immunoecology of microbes in lungs
4: Pneumonia
5: Respiratory microbiome changes during pneumonia
6: Oral microbiome relation to pulmonary microbiome
7: Pulmonary-gut microbiome cross talk
8: Strategies to prevent pneumonia by respiratory and gut microbiome modulation
9: Future directions and way forward
10: Conclusion
References
Further reading
Chapter Five: Gut microbiome dysbiosis in neonatal sepsis
Abstract
1: Introduction
2: Human neonatal gut microbiome
3: Dysbiosis of the neonatal gut microbiome
4: Factors modulating the neonatal microbiome
5: Neonatal sepsis
6: Measures to mitigate neonatal sepsis
7: Future directions
8: Conclusion
References
Further reading
Chapter Six: Diarrheal disease and gut microbiome
Abstract
1: Introduction
2: Composition of gut microbiome during diarrhea
3: Orchestrated mechanisms of commensals in preventing the pathogen colonization
4: Pathogen-mediated gut microbial modifications
5: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
6: Conclusion and future prospective
References
Chapter Seven: Gut microbiome dysbiosis in inflammatory bowel disease
Abstract
1: Introduction
2: Global epidemiology of inflammatory bowel disease
3: Clinical features of inflammatory bowel disease
4: Four major factors linked with inflammatory bowel disease
5: Microbiome based therapeutics for inflammatory bowel disease
6: Perspectives
7: Conclusion
References
Chapter Eight: Gut microbiome dysbiosis in malnutrition
Abstract
1: Introduction
2: Microbiome composition and dynamics in children
3: Early life perturbations of microbiome and associated health disorders
4: Factors influence the composition and diversity of microbiota in infants
5: Gut microbiome signatures in malnourished children
6: Microbiome-based therapeutics for malnourished children
7: Conclusion: Challenges and perspectives
Acknowledgments
References
Chapter Nine: Human microbiome and cardiovascular diseases
Abstract
1: Introduction
2: The gut metabolome and the host pathophysiology
3: Mechanism of interaction between the gut microbiome and the host
4: Gut microbiota, metabolome, and CVDs
5: Therapeutic uses of gut microbe/probiotics
6: Conclusion
References
Chapter Ten: Human gut microbiota and Parkinson's disease
Abstract
1: Parkinson's Disease
2: History
3: Etiology
4: Symptoms
5: Risk factors
6: Gut brain axis and gut microbiota
7: Gut microbiota dysbiosis in PD
8: Neuroinflammation and gut microbiota in Parkinson's disease
9: PD medications and the gut microbiota
10: Microbial metabolites in Parkinson's disease
11: Altered gene expression and associated pathways in Parkinson's disease patient's gut
12: Changes in nutrients profile in Parkinson's disease patients
13: Models to study microbiota brain axis
14: Implications of gut microbiota on brain
15: Gut microbiota induced PD progression
16: Knowledge gaps, conclusions and future prospects
Acknowledgments
References
Chapter Eleven: Vaginal microbiome dysbiosis in preterm birth
Abstract
1: Introduction
2: Normal vaginal microbiota
3: Variation in vaginal microbiome among ethnicities
4: Structure and functions of microbiome with birth outcomes
5: Conclusion
Acknowledgment
References
Index

Bhabatosh Das

Dr Bhabatosh Das is an Associate Professor in Translational Health Science and Technology Institute, an autonomous institute of the Department of Biotechnology, Government of India. He received his MSc degree (2000) from Visva-Bharati University, MTech degree (2002) from IIT-Kharagpur and PhD (2008) from IICB-Kolkata. He moved to France for his postdoctoral training and joined I2BC, France. Dr. Das is recipient of two international fellowships (i) CNRS, Govt. of France (ii) JSPS, Govt. of Japan and three national fellowships (i) IIT (ii) ICMR (iii) CSIR, Govt. of India. He has published 71 research articles 12 book chapters and received more than 2150 citations. Currently, he is Adjunct Visiting Faculty at MAHE-Manipal; Visiting Faculty at NIPER-Guwahati; Adjunct Faculty at RCB-Faridabad; Guest Lecturer at AIIMS-New Delhi. Dr. Das is Editorial Board Member in (i) Microbial Ecology (Springer group) (ii) Gut Microbiome (Cambridge University Press) and (iii) Current Indian Science (Bentham Science). He is guest associate editor in (i) Frontiers in Microbiology (ii) Frontiers in Genetics and (iii) Progress in Molecular Biology and Translational Research. He is a member in (i) GTFCC, WHO (ii) The Nutrition Society, London, UK and (iii) American Society for Microbiology, USA (Former). His current research focuses is Human microbiome and Bacterial antimicrobial resistance.

Affiliations and expertise

Associate Professor, Translational Health Science and Technology Institute (THSTI), NCR-BSC, India

Vijai Singh

Dr Vijai Singh is a Professor and Dean (Research & Innovation) at School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. He was an Associate Professor in the Department of Biosciences, School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. Prior this this, he was an Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, India and also an Assistant Professor in the Department of Biotechnology at the Invertis University, Bareilly, India. Prior to that, he was a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He received his Ph.D. in Biotechnology from the National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India with a research focus on the development of molecular and immunoassays for diagnosis of Aeromonas hydrophila. His research interests are focused on building novel biosynthetic pathways for production of medically and industrially important biomolecules. Additionally, his laboratory is working on CRISPR-Cas9 tools for genome editing. He has more than 11 years of research and teaching experience in synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has published 100 articles, 70 chapters, 15 books and 3 patents. He serves as an associate editor, editorial board member, and reviewer of several peer-reviewed journals. He is also a member of the Board of Study and Academic Council of Indrashil University and is the Member Secretary of the Institutional Biosafety Committee (IBSC) at the same University.

Affiliations and expertise

Department of Biosciences, School of Science, Indrashil University, Rajpur, Mehsana, India

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health